AGM/EGMApr 29, 2026, 05:22 PM
AEON Biopharma Sets 2026 Annual Meeting for June 17
AI Summary
AEON Biopharma, Inc. announced its 2026 Annual Meeting of Stockholders to be held on June 17, 2026, at its Irvine, California offices. Stockholders will vote on the election of two Class III directors, Marc Forth and Seongsoo Park, and the ratification of KPMG LLP as the independent registered public accounting firm for 2026. CEO Robert Bancroft expressed encouragement regarding the progress of ABP-450 and the company's focused strategy.
Key Highlights
- AEON Biopharma's 2026 Annual Meeting of Stockholders is scheduled for June 17, 2026.
- Stockholders will vote on the election of Marc Forth and Seongsoo Park as Class III directors.
- The meeting includes the ratification of KPMG LLP as the independent registered public accounting firm for 2026.
- The record date for stockholders entitled to vote at the Annual Meeting is April 21, 2026.
- CEO Robert Bancroft highlighted progress in advancing ABP-450 and executing a focused strategy.
- KPMG's audit fees were $1,124,500 in 2025 and $1,209,000 in 2024.
Price Impact
More from AEON